$WULF
TERAWULF INC. Stock $wulf

$wulf Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000143774921019685 Filed on August 12, 2021

Income Statement

Concept	2021 Q2	2020 Q2	2020 Q1
Revenue	$4.251M	$2.572M	$3.497M
YoY Change	65.27%	-44.03%	-0.89%
Cost Of Revenue	$2.822M	$2.188M	$2.344M
YoY Change	29.01%	-30.95%	-6.97%
Gross Profit	$1.429M	$384.9K	$1.153M
YoY Change	271.35%	-73.05%	14.28%
Gross Profit Margin	33.62%	14.96%	32.98%
Selling, General & Admin	$2.538M	$1.202M	$1.781M
YoY Change	111.09%	-10.2%	28.88%
% of Gross Profit	177.57%	312.37%	154.44%
Research & Development	$128.9K	$201.2K	$183.6K
YoY Change	-35.95%	-25.6%	2.65%
% of Gross Profit	9.02%	52.28%	15.92%
Depreciation & Amortization	$244.4K	$180.0K	$167.6K
YoY Change	35.77%	5.88%	3.45%
% of Gross Profit	17.1%	46.77%	14.54%
Operating Expenses	$4.267M	$1.404M	$1.965M
YoY Change	204.02%	-12.79%	25.87%
Operating Profit	-$4.267M	-$1.019M	-$811.4K
YoY Change	318.89%	463.11%	47.07%
Interest Expense	$82.50K	$24.62K	$21.48K
YoY Change	235.04%	9.36%	-3.55%
% of Operating Profit
Other Income/Expense, Net	$5.140K	$0.00	$10.00K
YoY Change		-100.0%	-50.0%
Pretax Income	-$721.5K	-$1.042M	-$825.9K
YoY Change	-30.73%	459.62%	48.08%
Income Tax	$823.00	$0.00	-$238.9K
% Of Pretax Income
Net Earnings	-$4.407M	-$1.042M	-$587.0K
YoY Change	323.14%	800.09%	29.0%
Net Earnings / Revenue	-103.66%	-40.49%	-16.79%
Basic Earnings Per Share	-$0.05	-$0.53	-$0.30
Diluted Earnings Per Share	-$0.05	-$0.53	-$0.30
COMMON SHARES
Basic Shares Outstanding	89.33M	1.976M	1.976M
Diluted Shares Outstanding	89.33M	1.976M	1.976M

Balance Sheet

Concept	2021 Q2	2020 Q2	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.261M	$3.000M	$2.600M
YoY Change	-24.64%	-6.25%	-27.78%
Cash & Equivalents	$2.261M	$2.978M	$1.605M
Short-Term Investments		$0.00	$1.000M
Other Short-Term Assets	$162.8K	$200.0K	$300.0K
YoY Change	-18.61%	-33.33%	0.0%
Inventory	$1.608M	$2.682M	$2.589M
Prepaid Expenses
Receivables	$1.651M	$1.414M	$1.760M
Other Receivables	$30.41K	$300.0K	$200.0K
Total Short-Term Assets	$5.713M	$7.480M	$7.508M
YoY Change	-23.63%	-11.16%	-12.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.084M	$7.714M	$7.868M
YoY Change	-8.17%	-3.41%	-2.08%
Goodwill
YoY Change
Intangibles	$245.8K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$7.330M	$7.968M	$8.136M
YoY Change	-8.01%	-3.76%	-3.24%
TOTAL ASSETS
Total Short-Term Assets	$5.713M	$7.480M	$7.508M
Total Long-Term Assets	$7.330M	$7.968M	$8.136M
Total Assets	$13.04M	$15.45M	$15.64M
YoY Change	-15.57%	-7.49%	-7.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.522M	$300.0K	$800.0K
YoY Change	407.25%	-40.0%	-11.11%
Accrued Expenses	$566.3K	$500.0K	$400.0K
YoY Change	13.26%	-16.67%	0.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$3.288M	$134.6K
YoY Change	-100.0%	2402.84%	3.87%
Total Short-Term Liabilities	$2.088M	$4.132M	$1.317M
YoY Change	-49.46%	233.61%	-3.88%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$681.5K	$2.654M
YoY Change	-100.0%	-75.27%	-4.83%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$681.5K	$2.654M
YoY Change	-100.0%	-76.81%	-10.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.088M	$4.132M	$1.317M
Total Long-Term Liabilities	$0.00	$681.5K	$2.654M
Total Liabilities	$2.088M	$4.813M	$3.971M
YoY Change	-56.62%	15.23%	-8.54%
SHAREHOLDERS EQUITY
Retained Earnings	$7.854M	$7.709M	$8.750M
YoY Change	1.88%	-19.72%	-10.11%
Common Stock	$3.101M	$2.927M	$2.923M
YoY Change	5.94%	0.2%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$23.86M	$10.64M	$11.67M
YoY Change
Total Liabilities & Shareholders Equity	$13.04M	$15.45M	$15.64M
YoY Change	-15.57%	-7.49%	-7.97%

Cashflow Statement

Concept	2021 Q2	2020 Q2	2020 Q1
OPERATING ACTIVITIES
Net Income	-$4.407M	-$1.042M	-$587.0K
YoY Change	323.14%	800.09%	29.0%
Depreciation, Depletion And Amortization	$244.4K	$180.0K	$167.6K
YoY Change	35.77%	5.88%	3.45%
Cash From Operating Activities	$568.2K	-$760.0K	-$427.3K
YoY Change	-174.76%	406.67%	-30.86%
INVESTING ACTIVITIES
Capital Expenditures	-$20.22K	$20.00K	$135.1K
YoY Change	-201.1%	-83.33%	15.42%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$980.0K	$1.240M
YoY Change	-100.0%		-639.13%
Cash From Investing Activities	-$20.22K	$960.0K	$1.105M
YoY Change	-102.11%	-900.0%	-413.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$35.68K
YoY Change			0.74%
Cash From Financing Activities	-2.715M	1.180M	-35.68K
YoY Change	-330.12%	-2460.0%	0.74%
NET CHANGE
Cash From Operating Activities	568.2K	-760.0K	-427.3K
Cash From Investing Activities	-20.22K	960.0K	1.105M
Cash From Financing Activities	-2.715M	1.180M	-35.68K
Net Change In Cash	-2.167M	1.380M	641.8K
YoY Change	-257.06%	-531.25%	-163.8%
FREE CASH FLOW
Cash From Operating Activities	$568.2K	-$760.0K	-$427.3K
Capital Expenditures	-$20.22K	$20.00K	$135.1K
Free Cash Flow	$588.4K	-$780.0K	-$562.4K
YoY Change	-175.44%	188.89%	-23.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001083301
	dei	Entity Registrant Name EntityRegistrantName	IKONICS CORP
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1981194
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	54000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	55000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	205697	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	207399	USD
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	250000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	250000
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4750000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4750000
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1980694
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1980694
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1976354
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1976354
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P4Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2260855	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3693845	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1651035	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2119213	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	1607828	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1644975	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	162786	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	125969	USD
CY2021Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	30412	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	219451	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	5712916	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	7803453	USD
CY2021Q2	iknx	Land And Building LandAndBuilding	9556586	USD
CY2020Q4	iknx	Land And Building LandAndBuilding	9556586	USD
CY2021Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	5271367	USD
CY2020Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	5263586	USD
CY2021Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1420494	USD
CY2020Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1417219	USD
CY2021Q2	iknx	Vehicles Vehicles	245674	USD
CY2020Q4	iknx	Vehicles Vehicles	245674	USD
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16494121	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16483065	USD
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9410087	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9094702	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7084034	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7388363	USD
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	245832	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	243583	USD
CY2021Q2	us-gaap	Assets Assets	13042782	USD
CY2020Q4	us-gaap	Assets Assets	15435399	USD
CY2021Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2688396	USD
CY2021Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1521736	USD
CY2020Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	459836	USD
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	466547	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	279755	USD
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	99774	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	168066	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2088057	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3596053	USD
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	198069	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	197635	USD
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2902790	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2743930	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7853866	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8897781	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	10954725	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11839346	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13042782	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15435399	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4251348	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2572439	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7324756	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6069631	USD
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2822044	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2187544	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4899120	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4531504	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	1429304	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	384895	USD
	us-gaap	Gross Profit GrossProfit	2425636	USD
	us-gaap	Gross Profit GrossProfit	1538127	USD
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1944502	USD
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1202307	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3128093	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2983327	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	128895	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	201234	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	263817	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	384814	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-644093	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1018646	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-966274	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1830014	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	82498	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	24623	USD
	us-gaap	Interest Expense InterestExpense	102340	USD
	us-gaap	Interest Expense InterestExpense	46107	USD
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	5138	USD
CY2020Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1766	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	5175	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	8683	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-721453	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1041503	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1063439	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1867438	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	823	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-19524	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-238929	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-722276	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-1041503	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1043915	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1628509	USD
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.82
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.82
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1977959
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1976354
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1977368
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1976354
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1977959
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1976354
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1977368
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1976354
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	11561585	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-722276	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	21299	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	94117	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	10954725	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	11673380	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-1041503	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3688	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	10635565	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11839346	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1043915	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	27690	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	131604	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	10954725	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	12256698	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1628509	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7376	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	10635565	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1043915	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1628509	USD
	us-gaap	Depreciation Depreciation	315385	USD
	us-gaap	Depreciation Depreciation	335435	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	98548	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	18452	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	131604	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	7376	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	2324	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	16906	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-468178	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1020699	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-37147	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	501404	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	36817	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-749076	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-189039	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	247011	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1061900	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-446417	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	118500	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-511614	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1339569	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1189335	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11056	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	149916	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	18297	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	15958	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	12483	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	2205000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27014	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2060898	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1214500	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2773235	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	71603	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	27690	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2745545	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1142897	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1432990	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2014460	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3693845	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	963649	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2260855	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2978109	USD
	us-gaap	Interest Paid Net InterestPaidNet	24089	USD
	us-gaap	Interest Paid Net InterestPaidNet	37998	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	208562	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-8082	USD
CY2021Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	1286151	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1323655	USD
CY2021Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	399738	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	428753	USD
CY2021Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1140543	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1065458	USD
CY2021Q2	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	1218604	USD
CY2020Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	1172891	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	1607828	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1644975	USD
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	23500
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.45
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5165
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1977959
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1976354
CY2021Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2020Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1977959
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1976354
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1977368
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1976354
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1977368
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1976354
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	131600	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7400	USD
CY2021Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	674000	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	24000	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17500
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.97
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	11.50
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	9.23
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	10.75
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.54
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	58700	USD
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	20700	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	pure
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4251348	USD
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2822044	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	1429304	USD
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1944502	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	128895	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-644093	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2572439	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2187544	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	384895	USD
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1202307	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	201234	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1018646	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7324756	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4899120	USD
	us-gaap	Gross Profit GrossProfit	2425636	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3128093	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	263817	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-966274	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6069631	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4531504	USD
	us-gaap	Gross Profit GrossProfit	1538127	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2983327	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	384814	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1830014	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1651035	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2119213	USD
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001	pure
CY2020Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.000	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.018	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.128	pure
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD

Files In Submission

Name	View Source	Status
0001437749-21-019685-index-headers.html	Edgar Link	pending
0001437749-21-019685-index.html	Edgar Link	pending
0001437749-21-019685.txt	Edgar Link	pending
0001437749-21-019685-xbrl.zip	Edgar Link	pending
ex_256056.htm	Edgar Link	pending
ex_256057.htm	Edgar Link	pending
ex_256058.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
iknx-20210630.xsd	Edgar Link	pending
iknx-20210630_cal.xml	Edgar Link	unprocessable
iknx-20210630_def.xml	Edgar Link	unprocessable
iknx-20210630_lab.xml	Edgar Link	unprocessable
iknx-20210630_pre.xml	Edgar Link	unprocessable
ikon20210630_10q.htm	Edgar Link	pending
ikon20210630_10q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WULF
TERAWULF INC. Stock $wulf

2021 Q2 Form 10-Q Financial Statement

#000143774921019685 Filed on August 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WULF TERAWULF INC. Stock $wulf

2021 Q2 Form 10-Q Financial Statement

#000143774921019685 Filed on August 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WULF
TERAWULF INC. Stock $wulf